Illumina Acquires GRAIL For $8 Billion
socalTECH
SEPTEMBER 21, 2020
Illumina said the buy will help it add a multi-disciplinary team and capabilities for next generation sequencing (NGS), population scale clinical studies, and machine learning. GRAIL is developing a multi-cancer screening test. GRAIL was spun out of Illumina in 2016 as a standalone company. billion in cash and $4.5
Let's personalize your content